Neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma: a clinical retrospective study

Neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma: a clinical retrospective study

Abstract Background As neoadjuvant therapies become increasingly crucial in the management of esophageal squamous cell carcinoma (ESCC), improving local control, R0 resection rates, and overall survival, determining the optimal neoadjuvant strategy remains a priority. This study retrospectively asse...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiazhen Chen, Chuanwang Miao, Xiaoyue Wang, Liying Yang, Cunliang Wang, Yuanji Chen, Dan Zong, XuDong Hu, Xia He
Format: Article
Language:English
Published: BMC 2025-08-01
Series:BMC Cancer
Subjects:
Esophageal squamous cell carcinoma
Neoadjuvant therapy
Chemoradiotherapy
Immunotherapy
Online Access:https://doi.org/10.1186/s12885-025-14682-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-14682-z

Similar Items